ERG and prostate cancer: The TMPRSS2:ERG fusion process has also been described as involved in the regulation of long non-coding RNAs (lncRNAs), which are known to play an important role in the regulation of gene expression and to be deregulated in several types of cancer, including prostate cancer [52,53].